Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.5334
H.R.5334: To amend chapter V of the Federal Food, Drug, and Cosmetic Act to expedite the development and review of breakthrough therapies.
About This Bill
- This bill was introduced in the 112th Congress
- This bill is primarily about health
- Introduced May 7, 2012
- Latest Major Action May 11, 2012
Bill Sponsor
Bill Cosponsor
Bill Summary
Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services (HHS), at the request of the sponsor of a drug, to expedite the drug's development and review if: (1) it is intended, either alone or in combination, to treat a serious life-threatening disease or condition; and (2) preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
|
Referred to the House Committee on Energy and Commerce.
|
|
|
Referred to the Subcommittee on Health.
|
|
| May 7, 2012 |
Introduced in the House by Brian P. Bilbray (R-Calif.) |